Filtered By:
Source: The Journal of Thoracic and Cardiovascular Surgery
Management: Hospitals
Procedure: Heart Valve Surgery

This page shows you your search results in order of date.

Order by Relevance | Date

Total 7 results found since Jan 2013.

Commentary: Mid-term outcomes in a real-world transcatheter aortic valve replacement population
In this edition of the Journal, Percy and colleagues1 present a series of 866 patients who underwent transfemoral transcatheter aortic valve replacement (TAVR) at Brigham and Women's Hospital between 2011 and 2018. The authors compared 5-year survival in patients with and without periprocedural complications. The complications of interest were periprocedural stroke, paravalvular leak (PVL), new left bundle branch block, and permanent pacemaker (PPM) implantation. These complications appear to occur more frequently after TAVR than surgical aortic valve replacement (SAVR) in some randomized trials.
Source: The Journal of Thoracic and Cardiovascular Surgery - May 14, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Rachel Eikelboom, Aaron J. Spooner, Michael H. Yamashita Tags: Commentary Source Type: research

Commentary: In the era of mitral valve-in-valve therapy, mechanical prosthesis in young patients does not deserve to be forgotten
Chen and colleagues1 from Memorial Hospital of Taoyaun in Taiwan analyzed, retrospectively, the results of patients who received either biological or mechanical valve for mitral valve replacement in rheumatic heart disease. Patient data were extracted from the National Health Insurance administrative database in Taiwan. Propensity score analysis yielded 2 paired groups of 788 patients. No significant difference in terms of in-hospital mortality were observed between the 2 matched groups. Regarding late outcomes, all-cause mortality at 10  years was in favor of the mechanical valve group, risk of stroke tended to be higher...
Source: The Journal of Thoracic and Cardiovascular Surgery - April 1, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Francesco Formica, Francesco Maestri, Francesco Nicolini Tags: Commentary Source Type: research

Commentary: Atrial fibrillation after aortic valve replacement: Predict, prevent, protect
When atrial fibrillation (AF) occurs after cardiac surgery, surgeons consider the arrhythmia a nuisance rather than a complication. This reflects natural optimism. Although perioperative AF is most often self-limited, it is associated with increased risk of stroke and death, increased hospital length of stay, and increased health care costs.1 Still, we tend not to worry too much because postoperative AF tends to resolve regardless of treatment strategy.1
Source: The Journal of Thoracic and Cardiovascular Surgery - June 13, 2019 Category: Cardiovascular & Thoracic Surgery Authors: Marc Gillinov, Edward G. Soltesz Tags: Commentary Source Type: research

In-hospital mortality and stroke after surgical aortic valve replacement: A nationwide perspective
Stroke is a widely recognized complication after aortic valve replacement (AVR), especially among elderly patients. The literature contains substantial variability in reports of the actual incidence of stroke after AVR among high-risk patients. Our objective was to define risk of stroke in patients undergoing surgical AVR, using a large national database.
Source: The Journal of Thoracic and Cardiovascular Surgery - June 4, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Shikhar Agarwal, Aatish Garg, Akhil Parashar, Lars G. Svensson, E. Murat Tuzcu, Jose L. Navia, Stephanie Mick, Samir R. Kapadia Tags: Acquired cardiovascular disease Source Type: research

In-hospital Mortality and Stroke Following Surgical Aortic Valve Replacement: A Nationwide Perspective
Stroke is a widely recognized complication following aortic valve replacement (AVR), especially among elderly patients. Significant heterogeneity exists in the current literature around the actual incidence of stroke following AVR among high-risk patients. Our objective was to define risk of stroke in patients undergoing surgical AVR from a large national database.
Source: The Journal of Thoracic and Cardiovascular Surgery - June 4, 2015 Category: Cardiovascular & Thoracic Surgery Authors: Shikhar Agarwal, Aatish Garg, Akhil Parashar, Lars G. Svensson, E. Murat Tuzcu, Jose Navia, Stephanie Mick, Samir R. Kapadia Source Type: research

Protecting the aorta during transcatheter aortic valve replacement: Have we found the answer?
Neurologic injury ranging from transient cognitive dysfunction to catastrophic permanent stroke constitutes the single main morbidity of cardiac surgery and largely affects modern transcatheter aortic valve replacement (TAVR).1-3 Today, the incidence of cerebrovascular events after TAVR ranges from 3% to 7%.4 In the current report, Samim and colleagues5 have explored one of the novel embolic protection devices (EPDs) aimed at reducing these extremely pervasive complications that often carry surmountable challenges to the patient in terms of a reduction in functional status and quality of life, and the healthcare provider i...
Source: The Journal of Thoracic and Cardiovascular Surgery - December 6, 2014 Category: Cardiovascular & Thoracic Surgery Authors: Hanna A. Jensen, Amjad Syed, Vinod H. Thourani Tags: Editorial commentary Source Type: research

Effect of severe left ventricular systolic dysfunction on hospital outcome after transcatheter aortic valve implantation or surgical aortic valve replacement: Results from a propensity-matched population of the Italian OBSERVANT multicenter study
Objective: Despite demonstration of the superior outcomes of transcatheter aortic valve implantation (TAVI) versus optimal medical therapy for severe left ventricular systolic dysfunction, studies comparing TAVI and surgical aortic valve replacement (AVR) in this high-risk group have been lacking.Methods: We performed propensity matching for age, gender, baseline comorbidities, previous interventions, priority at hospital admission, frailty score, New York Heart Association class, EuroSCORE, and associated cardiac diseases. Next, the 30-day mortality and procedure-related morbidity of 162 patients (81 TAVI vs 81 AVR) with ...
Source: The Journal of Thoracic and Cardiovascular Surgery - November 21, 2013 Category: Cardiovascular & Thoracic Surgery Authors: Francesco Onorati, Paola D’Errigo, Claudio Grossi, Marco Barbanti, Marco Ranucci, Daniel Remo Covello, Stefano Rosato, Alice Maraschini, Gennaro Santoro, Corrado Tamburino, Fulvia Seccareccia, Francesco Santini, Lorenzo Menicanti, OBSERVANT Research Gro Tags: Acquired Cardiovascular Disease Source Type: research